Work with your PlexusDx provider to establish a schedule that minimizes GI upset while maintaining therapeutic benefit
Our Featured Weight-Loss Products Compounded Tirzepatide Injections Dual-action GLP-1 and GIP receptor agonist Starting at $349/month Benefits may include: Up to 10% weight loss* Slowed digestion Reduced appetite Blood sugar regulation Easy use Compounded Semaglutide Injections GLP-1 receptor agonist Starting at $249/month Benefits may include: Up to 10% weight loss* Slowed digestion Reduced appetite Blood sugar regulation Easy use Wegovy GLP-1 receptor agonist FDA-approved for chronic weight management Starting at $349/month Benefits may include: Up to 20% weight loss** Slowed digestion Reduced cravings Healthy metabolic function Clinically-proven treatment Zepbound Dual-action GLP-1 receptor agonist FDA-approved for chronic weight management Starting at $349/month Benefits may include: Slowed digestion Regulated blood sugar More controlled appetite Managed blood sugar GLP-1 Liquid Drops Oral semaglutide GLP-1 Starting at $229/month Benefits may include: Needle-free support Feeling full longer Slowed digestion Healthy blood sugar levels GLP-1 Lozenges Oral GLP-1 Starting at $199/month Benefits may include: Needle-free support Feeling full longer Slowed digestion Healthy blood sugar levels Mouth-dissolving formula MIC + B12 Energy and metabolism support Starting at $115/month Benefits may include: Regulated appetite Metabolic support Enhanced focus and clarity Energy support Naltrexone + Bupropion Support for balanced eating habits Starting at $115/month Benefits may include: Reduced cravings Reduced food noise Improved mood Gentle weight-loss support Metformin + Naltrexone + Topiramate Triple medication capsule to support your wellness goals Starting at $169/month Benefits may include: Needle-free support Metabolic health support Healthy appetite cues Improved insulin sensitivity **In clinical trials of Wegovy, average weight loss was about 15% overall, with up to ~20% seen in longer-term or higher-adherence trial groups, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone)
Once your endocrinologist confirms thyroid control, semaglutide injection or oral options from PlexusDx can be evaluated safely
With the EDs high-tech capabilities and smart design, our medical experts can still personalize care even amid a life-threatening situation
Its activity has been linked to enhanced oxytocin release in hypothalamic structures, which may influence cortical and subcortical connectivity
Second Natures published outcomes data shows members on our GLP-1 programmes lose an average of 19.1% of their starting body weight at 12 months, with 77.7% achieving a clinically meaningful loss of 10% or more
